PAVmed (PAVM) Inventory Average (2017 - 2024)
PAVmed's quarterly Inventory Average came in at $548500.0 in Q2 2024, up 59.45% quarter-over-quarter from $344000.0 in Q1 2024.
PAVmed has reported Inventory Average for 4 years, with the latest figure at $548500.0 in Q2 2024.
- For the quarter ending Q2 2024, Inventory Average changed N/A year-over-year to $548500.0; the trailing twelve-month figure through Jun 2024 stood at $548500.0 (changed N/A YoY), and the FY2023 full-year result was $194500.0, changed N/A from the prior year.
- Inventory Average for Q2 2024 stood at $548500.0, up from $344000.0 in the prior quarter.
- The five-year high for Inventory Average was $548500.0 in Q2 2024, with the low at $254000.0 in Q2 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 6.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.36 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.23 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 1.12 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.49 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 661.35 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 652.65 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 548,500.00 |
| Mar 31, 2024 | 344,000.00 |
| Jun 30, 2020 | 254,000.00 |
| Sep 30, 2018 | 87,941.50 |
| Jun 30, 2018 | 74,291.50 |
| Mar 31, 2018 | 59,667.00 |
| Dec 31, 2017 | 49,917.00 |
| Sep 30, 2017 | 67,667.00 |